Variant CJD: The present position and future possibilities

International Journal of Pediatric Otorhinolaryngology

Volumn 67, Issue SUPPL. 1, 2003, Pages

  Knight, Richard ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

CJD; Prion; Tonsil; Variant CJD

Indexed keywords

ISOPROTEIN; PRION PROTEIN;

APPENDIX; CATTLE; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; DISEASE TRANSMISSION; FATALITY; FOOD CONTAMINATION; HUMAN; LYMPHOID TISSUE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; TONSIL;

EID: 0344305451     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2003.08.030     Document Type: Conference Paper

References (18)

1. S.B. Prusiner, An introduction to prion biology and diseases, in: S.B. Prusiner (Ed.), Prion Biology and Diseases, Cold Spring Harbour Laboratory Press, New York, 1999, pp. 1-66.
2. Collins S., Law M.G., Fletcher A., Boyd A., Kaldor J., Masters C.L. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet. 353:1999;693-697.
3. Ward H.J.T., Everington D., Croes E.A., Alperovitch A., Delasnerie-Laupretre N., Zerr I.et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology. 59:2002;543-548.
4. H. Baron, J. Safar, D. Groth, J. DeArmond, S.B. Prusiner, Biosafety issues in prion diseases, in: S.B. Prusiner (Ed.), Prion Biology and Diseases, Cold Spring Harbour Laboratory Press, New York, 1999, pp. 743-777.
5. Brown P., Preece M., Brandel J.-P., Sato T., McShane L., Zerr I. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology. 55:2000;1075-1081.
6. R.G. Will, M.P. Alpers, D. Dormont, L.B. Schonberger, J. Tateishi, Infectious and sporadic prion diseases, in: S.B. Prusiner (Ed.), Prion Biology and Diseases, Cold Spring Harbour Laboratory Press, New York, 1999, pp. 465-507.
7. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith P.G. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925.
8. Knight R. The relationship between new variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Vox Sang. 76:1999;203-208.
9. Bruce M.E.et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature. 389:1997;498-501.
10. Hill A.F.et al. The same prion strain causes vCJD and BSE. Nature. 389:1997;448-450.
11. Scott M.R., Will R., Ironside J., Nguyen H.-O.B., Tremblay P., DeArmond S.J., Prusiner S.B. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. PNAS. 21:1999;15137-15142.
12. Bruce M.E., McConnell I., Will R.G., Ironside J.W. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet. 358:2001;208-209.
13. Andrews N.J., Farrington C.P., Cousens S.N., Smith P.G., Ward H., Knight R.S.G.et al. Incidence of variant Creutzfeldt-Jakob disease in the UK. Lancet. 356:2000;481-482.
14. Creutzfeldt-Jakob Disease Surveillance in the United Kingdom, Tenth Annual Report, National CJD Surveillance Unit, London School of Hygiene and Tropical Medicine, 2001.
15. Website: http://www.oie.int.
16. Hilton D.A., Fathers E., Edwards P., Ironside J.W., Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet. 353:1999;1271.
17. Ironside J.W., Hilton D.A., Ghani A., Johnston N.J., Conyers L., McCardle L.M.et al. Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet. 355:2000;1693-1694.
18. Transmissible Spongiform Encephalopathy Agents: Safe Working and the Prevention of Infection, Advisory Committee on Dangerous Pathogens, The Stationery Office, 1998.